OSTX Operating Income from 2010 to 2024

OSTX Stock   3.02  1.44  32.29%   
OS Therapies Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income will likely drop to about -4.6 M in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit OS Therapies Incorporated generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2010-12-31
Previous Quarter
-4.3 M
Current Value
-4.6 M
Quarterly Volatility
165.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Selling General Administrative of 1 M or Total Revenue of 0.0, as well as many indicators such as . OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
  
Check out the analysis of OS Therapies Correlation against competitors.

Latest OS Therapies' Operating Income Growth Pattern

Below is the plot of the Operating Income of OS Therapies Incorporated over the last few years. Operating Income is the amount of profit realized from OS Therapies operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of OS Therapies Incorporated is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. OS Therapies' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
Operating Income10 Years Trend
Slightly volatile
   Operating Income   
       Timeline  

OSTX Operating Income Regression Statistics

Arithmetic Mean(4,759,799)
Coefficient Of Variation(3.48)
Mean Deviation124,090
Median(4,837,355)
Standard Deviation165,720
Sample Variance27.5B
Range494.7K
R-Value0.66
Mean Square Error16.6B
R-Squared0.44
Significance0.01
Slope24,523
Total Sum of Squares384.5B

OSTX Operating Income History

2024-4.6 M
2023-4.3 M
2022-4.4 M

About OS Therapies Financial Statements

OS Therapies investors use historical fundamental indicators, such as OS Therapies' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Income-4.3 M-4.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.